Dose and Duration of Upfront Steroid Administration Have no Prognostic Impact in Dogs With Multicentric Diffuse Large B‐Cell Lymphoma
Fuente:
Wiley Open Access
Enregistré dans:
| Auteurs principaux: | Ilaria Maga, Silvia Sabattini, Valeria Martini, Fulvio Riondato, Luca Aresu, Laura Marconato |
|---|---|
| Format: | Artículo Open Access |
| Publié: |
Wiley
2025
|
| Sujets: | |
| Accès en ligne: | |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
Prognostic Impact of Mast Cell Infiltration Detected by Flow Cytometry on Excised Sentinel Lymph Nodes in Dogs With Newly Diagnosed Mast Cell Tumours
par: Carmit Chalfon, et autres
Publié: (2025)
par: Carmit Chalfon, et autres
Publié: (2025)
Expanding the Spectrum of Canine Diffuse Large B‐Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis
par: Antonella Fanelli, et autres
Publié: (2025)
par: Antonella Fanelli, et autres
Publié: (2025)
Flow Cytometry for the Detection and Quantification of Mast Cells in Lymph Nodes: A Prospective Study in 64 Dogs With Mast Cell Tumour
par: Giulia Iamone, et autres
Publié: (2024)
par: Giulia Iamone, et autres
Publié: (2024)
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma
par: Dina Guerra, et autres
Publié: (2025)
par: Dina Guerra, et autres
Publié: (2025)
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs
par: Latasha Ludwig, et autres
Publié: (2025)
par: Latasha Ludwig, et autres
Publié: (2025)
Blood Neutrophil‐to‐Lymphocyte Ratio as a Potential Prognostic Marker in Dogs ≤10 kg With Multicentric Lymphoma
par: SoYoung Park, et autres
Publié: (2024)
par: SoYoung Park, et autres
Publié: (2024)
Vinorelbine as a Rescue Treatment for Canine Histiocytic Sarcoma: A Multicentre Retrospective Study of 18 Dogs
par: Nina Vigevani, et autres
Publié: (2025)
par: Nina Vigevani, et autres
Publié: (2025)
Phase 1 Dose Escalation of Single‐Agent Mechlorethamine in Dogs With Lymphoma
par: Laura E. Chadsey, et autres
Publié: (2025)
par: Laura E. Chadsey, et autres
Publié: (2025)
Incorporation of Biologic Variables Into the Staging for Canine Cutaneous and Subcutaneous Mast Cell Tumours: Proposal of the UBo pTNM System
par: Laura Marconato, et autres
Publié: (2024)
par: Laura Marconato, et autres
Publié: (2024)
Vincristine Induced Adverse Effects in Lymphoma Bearing Dogs With Asymptomatic Neutropenia at the Time of Drug Administration
par: Albert Thomas, et autres
Publié: (2024)
par: Albert Thomas, et autres
Publié: (2024)
Genotoxic Herbicide Exposures in Golden Retrievers With and Without Multicentric Lymphoma
par: Ashleigh N. Tindle, et autres
Publié: (2025)
par: Ashleigh N. Tindle, et autres
Publié: (2025)
Use of Lomustine and Prednisolone as First‐Line Treatment in Canine Multicentric Lymphoma
par: Chiara Catalucci, et autres
Publié: (2024)
par: Chiara Catalucci, et autres
Publié: (2024)
Application of 1H NMR Metabolic Profiling of Serum in Canine Multicentric Lymphoma
par: Rosina Sánchez Solé, et autres
Publié: (2024)
par: Rosina Sánchez Solé, et autres
Publié: (2024)
Impact of 10% Dose Reductions and Duration of Treatment Delays in the Management of Chemotherapy‐Induced Neutropenia in Dogs Treated With Common Chemotherapy Protocols: A Single‐Centre Experience
par: Suzanne Busser, et autres
Publié: (2024)
par: Suzanne Busser, et autres
Publié: (2024)
Brain Dose–Volume Thresholds and Survival in Dogs With Intracranial Tumours Treated With the 10 × 4 Gy Radiotherapy Schedule: A Combined Analysis of Two Trials
par: Sergejs Unterkirhers, et autres
Publié: (2025)
par: Sergejs Unterkirhers, et autres
Publié: (2025)
Outcome and Prognostic Factors of Dogs Treated for Infiltrative Lipoma Undergoing Radiation Therapy: A Retrospective Multi‐Institutional Study of 29 Cases
par: Arata Matsuyama, et autres
Publié: (2025)
par: Arata Matsuyama, et autres
Publié: (2025)
Mediastinal Lymphoma in 70 Dogs Treated With Lomustine or Anthracycline‐Based Multi‐Agent Chemotherapy
par: Diogo Machado, et autres
Publié: (2026)
par: Diogo Machado, et autres
Publié: (2026)
Impacts of Vincristine and Prednisolone Chemotherapy on the Canine Gut Microbiota in Dogs Undergoing Treatment for Lymphoma
par: Juan Aragon, et autres
Publié: (2025)
par: Juan Aragon, et autres
Publié: (2025)
Prognostic Impact of a Histologic Grading Scheme in Dogs Diagnosed With Rib Chondrosarcoma
par: Margaret L. Musser, et autres
Publié: (2024)
par: Margaret L. Musser, et autres
Publié: (2024)
Tolerability and Adverse Event Profile of Fixed Dose Rate Gemcitabine in Dogs With Neoplasia
par: Evangelia J. Makrygiannis, et autres
Publié: (2026)
par: Evangelia J. Makrygiannis, et autres
Publié: (2026)
Prognostic Value of a Histopathological Scoring System and the Ki67 Proliferation Index in Dogs With Phaeochromocytoma
par: Marit F. van den Berg, et autres
Publié: (2025)
par: Marit F. van den Berg, et autres
Publié: (2025)
Prognostic Role of Patient, Tumour and Radiomic Factors Influencing Outcomes in Dogs With Thyroid Cancer Treated With Iodine‐131
par: Ibrahim Chamseddine, et autres
Publié: (2025)
par: Ibrahim Chamseddine, et autres
Publié: (2025)
A Multi‐Institutional Retrospective Study of 21 Dogs Having Undergone Hypofractionated Radiotherapy for Adrenal Tumours (2017–2024)
par: Yen‐Hao Erik Lai, et autres
Publié: (2026)
par: Yen‐Hao Erik Lai, et autres
Publié: (2026)
Population Pharmacokinetics, Pharmacodynamics and Safety Properties of Trametinib in Dogs With Cancer: A Phase I Dose Escalating Clinical Trial
par: Marilia Takada, et autres
Publié: (2024)
par: Marilia Takada, et autres
Publié: (2024)
A retrospective Italian Society of Veterinary Oncology (SIONCOV) study of 56 cats with appendicular osteosarcoma
par: Laura Marconato, et autres
Publié: (2024)
par: Laura Marconato, et autres
Publié: (2024)
Do Pre‐Treatment Biopsy Characteristics Predict Early Tumour Progression in Feline Diffuse Large B Cell Nasal Lymphoma Treated With Radiotherapy?
par: Valerie J. Poirier, et autres
Publié: (2024)
par: Valerie J. Poirier, et autres
Publié: (2024)
Evaluation of Decreased Kidney Function in Dogs Receiving Carboplatin: A Retrospective Cohort Study of 98 Dogs (2006–2024)
par: Andrew D. Yale, et autres
Publié: (2025)
par: Andrew D. Yale, et autres
Publié: (2025)
Immunophenotyping and Mutation Analysis of Canine Intestinal T‐Cell Lymphoma: A Comparative Pathological Study of Human Enteropathy‐Associated T‐Cell Lymphoma
par: Kazuhiro Kojima, et autres
Publié: (2025)
par: Kazuhiro Kojima, et autres
Publié: (2025)
Clinical Efficacy and Tolerability of Sorafenib in Dogs With Advanced Carcinomas
par: Doyun Kim, et autres
Publié: (2026)
par: Doyun Kim, et autres
Publié: (2026)
Immunological Pre‐Metastatic Niche in Dogs With Naturally Occurring Osteosarcoma
par: Mikael Kerboeuf, et autres
Publié: (2024)
par: Mikael Kerboeuf, et autres
Publié: (2024)
Serum Symmetric Dimethylarginine as a Predictor of Toxicity of Carboplatin in Dogs
par: Alexandra Gareau, et autres
Publié: (2025)
par: Alexandra Gareau, et autres
Publié: (2025)
Neurological Recovery in 14 Cats With Epidural Lymphoma Treated With Chemotherapy
par: Julya Nathalya Felix Chaves, et autres
Publié: (2025)
par: Julya Nathalya Felix Chaves, et autres
Publié: (2025)
Isolation of Tumour‐Derived Extracellular Vesicles From the Plasma of Dogs Affected by Intracranial Tumours Showing Heterologous and Cross‐Species Tropism: A Pilot Study
par: Simona Vincenti, et autres
Publié: (2024)
par: Simona Vincenti, et autres
Publié: (2024)
Tolerability Assessment of Orally Administered Paclitaxel With Encequidar in Dogs With Spontaneous Malignancy
par: Jordan Ziegler, et autres
Publié: (2025)
par: Jordan Ziegler, et autres
Publié: (2025)
Cross‐Species Transcriptomic and Network Analysis of Human and Canine Diffuse Large B‐Cell Lymphoma Identifies a Conserved Replication– DNA Damage Module for Drug Repurposing
par: Soroush Akbari‐Ardabili, et autres
Publié: (2026)
par: Soroush Akbari‐Ardabili, et autres
Publié: (2026)
Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs
par: Lily Thorsen, et autres
Publié: (2025)
par: Lily Thorsen, et autres
Publié: (2025)
Clinical Response to Imatinib Mesylate and Toxicity Profile in 35 Dogs With Mast Cell Tumours
par: Elisabetta Treggiari, et autres
Publié: (2025)
par: Elisabetta Treggiari, et autres
Publié: (2025)
Rescue Protocols for Canine Non‐Indolent B Cell Lymphoma: A Systematic Review
par: Claire Marie Cannon, et autres
Publié: (2026)
par: Claire Marie Cannon, et autres
Publié: (2026)
Evaluating the Impact of Elective Nodal Irradiation for Dogs With Oral Malignant Melanoma Undergoing Hypofractionated Radiotherapy
par: Patricia Gualtieri, et autres
Publié: (2025)
par: Patricia Gualtieri, et autres
Publié: (2025)
Recurrence Rates for Mandibular Fibrosarcoma Associated With Mandibular Canal Invasion Following Mandibulectomy Procedures in Dogs
par: Carley P. Johnson, et autres
Publié: (2026)
par: Carley P. Johnson, et autres
Publié: (2026)
Documents similaires
-
Prognostic Impact of Mast Cell Infiltration Detected by Flow Cytometry on Excised Sentinel Lymph Nodes in Dogs With Newly Diagnosed Mast Cell Tumours
par: Carmit Chalfon, et autres
Publié: (2025) -
Expanding the Spectrum of Canine Diffuse Large B‐Cell Lymphoma Genetic Aberrations Through Whole Genome Sequencing Analysis
par: Antonella Fanelli, et autres
Publié: (2025) -
Flow Cytometry for the Detection and Quantification of Mast Cells in Lymph Nodes: A Prospective Study in 64 Dogs With Mast Cell Tumour
par: Giulia Iamone, et autres
Publié: (2024) -
Serum Lactate Dehydrogenase as a Potential Prognostic Biomarker in Dogs With Appendicular Osteosarcoma
par: Dina Guerra, et autres
Publié: (2025) -
Classification and Prognostication of B‐Cell and T‐Cell Multicentric Lymphoma in Dogs Using Serum MicroRNAs
par: Latasha Ludwig, et autres
Publié: (2025)